Evidence map›Paper›PMID 43016872›Full record

ReviewFrontiers in nutrition2026

Vitamin E in diabetes-associated cognitive dysfunction: mechanistic rationale, current evidence and translational gaps.

Wenting Geng, Yihan Fan, Peng Li, Renjun Lv, Di Zhang, Hua Shao

Abstract readReview
In one paragraph

Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenting Geng *College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Yihan Fan *Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Neuroimmunology, Jinan, Shandong, China.
Peng Li *Medical Department, Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Renjun LvDepartment of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Di ZhangDepartment of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Hua ShaoCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes-associated cognitive dysfunction (DACD) is an increasingly recognized complication of diabetes mellitus and involves multiple interacting processes, including oxidative stress, neuroinflammation, synaptic dysfunction, impaired insulin signaling, and neurovascular dysfunction. Vitamin E, a lipid-soluble antioxidant comprising tocopherols and tocotrienols, has attracted interest because several of its biological actions are mechanistically relevant to these pathways. This mini-review provides a focused overview of the mechanistic rationale, current experimental and clinical evidence, and major translational gaps concerning vitamin E in DACD. Preclinical studies suggest that specific vitamin E isoforms and preparations may modulate oxidative stress and lipid peroxidation, inflammatory signaling and microglial activation, synaptic plasticity-related pathways, and insulin responsiveness, and may also influence neurovascular processes. However, much of this evidence derives from animal models, cellular systems, peripheral tissues, or disease settings other than DACD and therefore provides mechanistic rather than clinical efficacy evidence. Direct clinical evidence in patients with formally diagnosed DACD remains lacking. Small intervention studies in patients with type 2 diabetes have reported inconsistent cognitive outcomes, whereas observational associations between dietary vitamin E intake and cognition are largely derived from non-DACD populations and cannot establish causality. High-dose supplementation may also entail safety concerns. Thus, current evidence supports the biological plausibility of vitamin E as a candidate for further investigation but does not establish its preventive or therapeutic efficacy in DACD. DACD-specific randomized controlled trials are needed to determine whether particular vitamin E isoforms, doses, or intervention durations provide clinically meaningful cognitive benefits and to establish long-term safety.

Indexed as

diabetes-associated cognitive dysfunctioninsulin resistanceneuroinflammationneurovascular dysfunctionoxidative stresssynaptic plasticityvitamin E

Identifiers

PMID43016872
PMCPMC13752402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.